RAP Intrinsic Valuation and Fundamental Analysis - Resapp Health Ltd

Watchlist Manager

Watchlist

Price on Oct 14: 0.016 AUD

Market Cap: AU$13.8m

Prices of ASX stocks are not being updated. The latest RAP price on Alpha Spread is from Oct 14, 2026. Financials, forecasts and intrinsic value keep updating.

	Resapp Health Ltd ASX:RAP	AU
D	Del Monte Corp DUS:FDM	KY
I	Icade SA F:3IC	FR
	Rocky Mountain Chocolate Factory Inc (Delaware) F:RMFA	US

Intrinsic Value

RAP price has not been updated for more than 4 months. This may indicate that the stock has been delisted.

Is RAP undervalued or overvalued?

See the intrinsic value estimate for Resapp Health Ltd and find out whether today’s valuation is cheap or expensive by its own historical standards.

Do our valuations actually work? See backtest results .

RAP Intrinsic Value

Unlock

Today vs. history

See how today’s valuation compares with RAP’s past valuations and how the stock performed after similar periods.

See what happened next Free account required

Track Buy Zone

20% below Intrinsic Value

Get notified when the price drops into your buy zone

Current Price AU$0.02

Intrinsic Value Locked

Margin of Safety 20% Locked

Or choose another margin of safety

0% below Intrinsic Value

10% below Intrinsic Value

30% below Intrinsic Value

40% below Intrinsic Value

50% below Intrinsic Value

Custom

Fundamental Analysis

What Resapp Health Does

Health Care

ResApp Health Ltd. engages in the research and commercial development of ResApp technology for the purpose of providing health care solutions for respiratory disease. The company is headquartered in Brisbane, Queensland. The company went IPO on 2005-01-12. The firm provides point of care diagnostic solutions for telehealth that are integrated into existing platforms. The firm is focused on developing apps to provide instant clinical diagnostic tests and management tools directly to consumers and healthcare providers.

Headquarters: Australia AU
IPO date: Jan 12, 2005